Gestion de crise : le laboratoire Pfizer et la crise du Trovan

Étude de cas Entreprises & gestion Management organisation

Date de publication :

03/06/2009

Langue :

Anglais

Format :

.doc

Nombre de pages :

14 pages

Niveau :

expert

Consulté :

0 fois

Avis client :

non évalué

Validé par :

le comité Oboulo.com

9,95 € Ajouter au panier

Sommaire :

Sommaire

A crisis resulting from rushed decisions but which took time to expand
1. A crisis triggered immediately
2. But which took time to amplify
3. A crisis which had severe consequences at various levels
Various actors, multiple stakes
1. The victims and their families
2. The Nigerian government
3. The health authorities in the US and across the world
4. The media and the public opinion
How did Pfizer deal with the Trovan scandal?
1. Initial reaction after the consequences of the Trovan tests
2. Back to the US: denial of Trovan by FDA
3. Acceptance of the drug: from success to deaths
4. Resurgence of the Nigerian scandal
5. Massive attacks and unsuccessful lawsuits
6. Pfizer's strategy: silence, elusion and out-of-court agreement
Lessons drawn from the crisis and changes implemented
1. More social responsibility in the Third World Countries
2. Clinical trials improvements
3. A better communication
4. All means are good to maximize profits

Résumé :

We decided to study the trovan crisis that affected pfizer as we found it particularly interesting due to the circumstances which contributed to provoke it. Indeed, we thought it would be quite enriching to analyze how a pharmaceutical company supposed to act for the improvement of human life can handle this type of crisis and account for ethically reprehensible practices as well as for the loss of human lives. Such a crisis may be categorized as a transgression, as pfizer executives were perfectly aware of what they were realizing, they knew about the risks but decided to carry the operations on anyway. What was the company reaction to the crisis, and did it manage to regain the world's trust? These are the main questions we will answer after having analyzed the origins and consequences of the crisis, as well as the reactions of the different stakeholders.

The roots of the trovan scandal that hit pfizer finds its roots back in 1996, when the pharmaceutical company decided to test on Nigerian kids its new medicine called trovan, which was not approved nor authorized yet by the health authorities in the US, thus using human-beings as mere guinea pigs. pfizer took advantage of a tremendous meningitis epidemic which was striking Kano, a poor city in Nigeria, causing many deaths, especially among children.